April 29 (Reuters) - The U.S. Food and Drug Administration (FDA) on Monday published the final rule to ensure safety and effectiveness of laboratory developed tests (LDTs), which are designed, manufactured and used within a clinical laboratory. (Reporting by Mariam Sunny in Bengaluru; Editing by Shinjini Ganguli)
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
195.7 USD | +0.41% | -0.34% | -13.97% |
May. 30 | JPMorgan Adjusts Price Target on Laboratory Corp of America Holdings to $243 From $261 | MT |
May. 23 | Some of the biggest splits in Corporate America | RE |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
196.4 USD | +0.75% | +0.42% | 16.43B | ||
141.1 USD | -0.58% | +1.80% | 15.77B | ||
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.32% | 16.43B | |
+22.07% | 88.99B | |
-24.09% | 74.82B | |
+1.06% | 26.63B | |
+3.92% | 17.88B | |
+2.56% | 15.77B | |
+77.53% | 13.21B | |
+70.91% | 13.08B | |
+39.76% | 12.9B | |
+22.21% | 12.7B |
- Stock Market
- Equities
- LH Stock
- News Labcorp Holdings Inc.
- US FDA publishes final rule for laboratory developed tests